Carson Wealth (CWM LLC)
HRTX icon

Carson Wealth (CWM LLC)’s Heron Therapeutics HRTX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.1K Buy
28,890
+18,262
+172% +$21.2K ﹤0.01% 4318
2025
Q4 		$14K Sell
10,628
-34,387
-76% -$42.5K ﹤0.01% 4372
2025
Q3 		$57K Buy
45,015
+39,643
+738% +$62.9K ﹤0.01% 3423
2025
Q2 		$11K Buy
5,372
+1,706
+47% +$3.48K ﹤0.01% 4240
2025
Q1 		$8K Buy
3,666
+2,237
+157% +$4.34K ﹤0.01% 4217
2024
Q4 		$2K Sell
1,429
-9,563
-87% -$15.5K ﹤0.01% 4544
2024
Q3 		$22K Buy
10,992
+6,926
+170% +$16.5K ﹤0.01% 3294
2024
Q2 		$14K Buy
4,066
+4,057
+45,078% +$12.5K ﹤0.01% 3340
2024
Q1 		$0 Buy
+9
New +$23 ﹤0.01% 4496
2023
Q4 		– Sell
-450
Closed – – 4299
2023
Q3 		$0 Hold
450
– – ﹤0.01% 4316
2023
Q2 		$1K Sell
450
-67
-13% -$119 ﹤0.01% 3973
2023
Q1 		$1K Sell
517
-898
-63% -$2.25K ﹤0.01% 3845
2022
Q4 		$4K Sell
1,415
-435
-24% -$1.4K ﹤0.01% 3299
2022
Q3 		$8K Hold
1,850
– – ﹤0.01% 2818
2022
Q2 		$5K Sell
1,850
-130
-7% -$522 ﹤0.01% 2978
2022
Q1 		$11K Buy
1,980
+1,530
+340% +$11.2K ﹤0.01% 2420
2021
Q4 		$4K Buy
+450
New +$4.59K ﹤0.01% 2835
2021
Q2 		$7K Hold
450
– – ﹤0.01% 2247
2021
Q1 		$7K Hold
450
– – ﹤0.01% 2247
2020
Q4 		$7K Hold
450
– – ﹤0.01% 2247
2020
Q3 		$7K Hold
450
– – ﹤0.01% 2245
2020
Q2 		$7K Hold
450
– – ﹤0.01% 2245
2020
Q1 		$7K Hold
450
– – ﹤0.01% 2245
2019
Q4 		$7K Hold
450
– – ﹤0.01% 2245
2019
Q3 		$7K Hold
450
– – ﹤0.01% 2244
2019
Q2 		$7K Hold
450
– – ﹤0.01% 2244
2019
Q1 		$7K Buy
+450
New +$11.8K ﹤0.01% 2244

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return

Carson Wealth (CWM LLC)'s HRTX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Heron Therapeutics (HRTX) stake by 172% in Q1 2026, buying an estimated $21.2K and bringing the position to 28,890 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4318.

Carson Wealth (CWM LLC) first reported a position in HRTX in Q1 2019 and has held it in 27 quarters since. The position peaked at $57K in Q3 2025. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 28,890 shares of Heron Therapeutics worth $23.1K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 18,262 Heron Therapeutics shares in Q1 2026, an estimated $21.2K.
  • Heron Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4318 holding.
  • Carson Wealth (CWM LLC) first reported a position in Heron Therapeutics in Q1 2019 and has held it in 27 quarters since.
  • Carson Wealth (CWM LLC)'s Heron Therapeutics position peaked at $57K in Q3 2025.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.